[O2-1] Retrovirus2

[O2-1-5] Novel recombinant HIV model system reveals the fate of HIV activation and latency by parallel transcriptomic and epigenomic analysis

*Wajihah Binti Sakhor¹, Kenji Sugata¹, Benjy Jek Yang Tan¹, Kazuoki Monde², Chihiro Motozono³, Omnia Reda^1,4, Akhinur Rahman¹, Misaki Matsuo¹, Hitomi Nakamura⁵, Takamasa Ueno³, Yasuko Sagara⁵, Hiroaki Takeuchi⁶, Masahiro Ono⁷, Kenji Maeda^8,9, Yorifumi Satou¹ (1. Division of Genomics and Transcriptomics, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan, 2. Department of Microbiology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan, 3. Division of Infection and Immunity, Joint Research center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan, 4. Microbiology Department, High Institute of Public Health, Alexandria University, Egypt, 5. Department of Quality, Japanese Red Cross Kyushu Block Blood Center, Chikushino, Japan, 6. Department of Molecular Virology, Tokyo Medical and Dental University, Tokyo, Japan, 7. Department of Life Sciences, Faculty of Natural Sciences, Imperial College London, London, United Kingdom, 8. Division of Antiviral Therapy, Joint Research Center for Human Retrovirus Infection, Kagoshima University, Kagoshima, Japan, 9. National Center for Global Health and Medicine Research Institute, Tokyo, Japan)